Respiratory & Sleep Medicine\ COPD Flashcards
What is COPD?
A chronic lung disease characterised by airflow limitation caused by airway (inflammation, increased mucous) and parenchymal destruction
What is the strongest risk factor associated with the development of COPD?
Smoking
Does COPD worsen over time?
Yes, unlike asthma, COPD tends to be a progressive disease, especially if exposure to harmful substances usually smoking continues.
Reduction or elimination of exposures can significantly reduce the rate of lung function deterioration.
What are the two types of COPD?
Chronic bronchitis and emphysema
What is chronic bronchitis?
- Chronic bronchitis is a chronic expiratory airflow obstruction with a cough, and excessive sputum production for at least three months in a year for two years.
What is emphysema?
- emphysema is chronic expiratory airflow obstructionwith enlargement of the airways, destruction of the alveoli and loss of elasticity of the alveolar walls.
Panacinar emphysema and lver cirrhosis developing in a young non-smoking patient is most likely due to what genetic disease?
- alpha 1-antitrypsin deficiency
What are the common symptoms associated with COPD?
- Cough
- dyspnea
- excessive sputum production
Patient with COPD have what typical findings on chest X-ray?
- ususally normal, but in advanced disease you may see flattened diaphragms, enlarged lung fields, increased AP diameter or interstitial markings with bullae.
patients with COPD, have what typical findings in EKG?
- usually normal but you may see
- poor wave progression in this V1 to V6
- right sided heart strain or
- low voltage QRS due to increased chest diameter
Do you have to document a flow obstruction on PFT is to make the diagnosis of COPD?
Yes, COPD is not a clinical diagnosis, but one that is made by spirometry.
In COPD, is residual lung volume increased or decreased compared to patients without COPD?
increased.
In most COPD patients, what do spirometric measurements (FEV1, FEV1/FVC) show pre and post bronchodilator therapy?
- Reduced FEV1 pre-bronchodilator therapy indicates airway obstruction.
- airway obstruction is largely irreversible.
- Some COPD patients show mild post-bronchodilator FEV1 improvement, especially if their disease has a component of asthma.
- However, the post bronchodilator FEV1/FVC ratio ratio always remained below 0.7 in COPD.
The Global Initiative for Chronic Obstructive Pulmonary disease (GOLD) recommends taking diagnostic spirometric measurements after administration of a bronchodilator, to reduce testing variability.
According to GOLD what FEV1/FVC, and FEV1 values, are consistent with COPD?
According to GOLD in COPD, post bronchodilator FEV1/FVC is less than 0.7 and FEV1 one is less than 80% of predicted.
Mild (stage I) COPD
- FEV1/FVC < 70%, FEV1 >/= 80% predicted
- with or without symptoms
Mild (stage I) COPD
- treatment
- FEV1/FVC < 70%, FEV1 >/= 80% predicted
- with or without symptoms
moderate(stage II) COPD
- FEV1/FVC < 70%
- FEV1 = 50- 80% predicted
- dyspnea with exertion
- with or without cough and sputum production
moderate(stage II) COPD
- treatment
- FEV1/FVC < 70%
- FEV1 = 50- 80% predicted
- dyspnea with exertion
- with or without cough and sputum production
- Short acting bronchodilators + one or more LABA or anticholinergics + pulmonary rehabilitation